Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

8.97
Delayed Data
As of 9:35am ET
 +0.148 / +1.68%
Today’s Change
7.51
Today|||52-Week Range
14.00
-19.71%
Year-to-Date
No recent news for ADMA Biologics Inc.

Today’s Trading

Previous close8.82
Today’s open8.97
Day’s range-- - --
Volume276
Average volume (3 months)11,207
Market cap$94.4M
Dividend yield--
Data as of 9:35am ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+23.95%
Earnings growth (this year)+2.82%
Earnings growth (next 5 years)--
Revenue growth (last year)+92.84%
P/E ratioNM
Price/Sales17.55
Price/Book13.64

Competitors

 Today’s
change
Today’s
% change
PIPPharmAthene Inc0.000.00%
BINDBIND Therapeutics In...+0.08+1.63%
TENXTenax Therapeutics I...+0.06+1.75%
CRMDCorMedix Inc0.000.00%
Data as of 9:35am ET, 09/03/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$5.9M
Annual profit (last year)-$16.8M
Net profit margin-284.22%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Adam S. Grossman
Chief Financial Officer &
Vice President
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts

Partner Offers